EP
SIBN icon

Eversept Partners’s SI-BONE Inc SIBN Stock Holding History

Eversept Partners’s Portfolio SIBN Stock Details SIBN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-258,094
Closed -$5.73M – 104
2021
Q4 		$5.73M Buy
258,094
+108,094
+72% +$2.33M 0.37% 61
2021
Q3 		$3.21M Buy
+150,000
New +$3.8M 0.22% 61

Other funds holding SIBN

Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Eversept Partners's SIBN Position: Q1 2022 in Review

Eversept Partners sold out of SI-BONE Inc (SIBN) in Q1 2022, closing a stake of 258,094 shares — an estimated $5.73M sold.

Eversept Partners first reported a position in SIBN in Q3 2021 and held it in 2 quarters. The position peaked at $5.73M in Q4 2021. 110 funds tracked by Wall St. Rank hold SIBN as of Q1 2022.

  • Eversept Partners reported no remaining SI-BONE Inc position as of Q1 2022 after selling out during the quarter.
  • Eversept Partners sold 258,094 SI-BONE Inc shares in Q1 2022, an estimated $5.73M.
  • Eversept Partners first reported a position in SI-BONE Inc in Q3 2021 and held it in 2 quarters.
  • Eversept Partners's SI-BONE Inc position peaked at $5.73M in Q4 2021.
  • 110 funds tracked by Wall St. Rank held SI-BONE Inc as of Q1 2022.

Based on Eversept Partners's 13F filing for Q1 2022, filed 16 May 2022.